US stock return on invested capital analysis and economic value added calculations to identify truly exceptional businesses. Our quality metrics help you find companies that generate superior returns on capital employed.
As of 2026-04-06, Theriva Biologics Inc. (TOVX) is trading at $0.25 per share, posting an intraday gain of 8.09% at the time of writing. No recent earnings data is available for the firm as of this analysis, so price action is currently being driven by technical levels, broader sector sentiment, and investor expectations for upcoming corporate catalysts. This analysis outlines key near-term technical markers, market context for small-cap biotech trading, and potential short-term price scenarios
Will Theriva Biologics (TOVX) Stock Grow in 2026 | Price at $0.25, Up 8.09% - Hot Momentum Watchlist
TOVX - Stock Analysis
4951 Comments
1667 Likes
1
Chennel
New Visitor
2 hours ago
Anyone else thinking the same thing?
π 134
Reply
2
Crisleidy
Expert Member
5 hours ago
Thatβs some award-winning stuff. π
π 100
Reply
3
Lachell
New Visitor
1 day ago
Wish I had discovered this earlier.
π 171
Reply
4
Shekerra
Trusted Reader
1 day ago
Market breadth is moderate, reflecting mixed participation across different stock categories.
π 42
Reply
5
Cesc
Expert Member
2 days ago
Volatility is elevated, indicating that short-term traders are actively adjusting their positions.
π 82
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.